Curis logo

Curis CRIS

$ 0.6 13.21%
report update icon

Quarterly report 2026-Q3
added 11-13-2026

Country

usaUSA

IPO year

-

Industry

Biotechnology

Stock Exchange

NASDAQ GLOBAL

Shares

13.2 M

Market Cap[1]

$ 7.9 M

EBITDA (LTM)

$ -10.5 M

P/E (LTM)

0.01249

P/S (LTM)

0.627323

EPS (LTM)

36.03

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
BioNTech SE BioNTech SE
BNTX
$ 83.55 -1.55 % $ 20.2 B Nasdaq Global Select Market germanyGermany
Cue Biopharma Cue Biopharma
CUE
$ 4.71 66.27 % $ 446 M Nasdaq Capital Market,SPB usaUSA
AIM ImmunoTech AIM ImmunoTech
AIM
$ 0.13 -3.75 % $ 210 K NYSE American usaUSA
AC Immune SA AC Immune SA
ACIU
$ 2.11 -0.24 % $ 213 M Nasdaq Global Market schweizSchweiz
DBV Technologies S.A. DBV Technologies S.A.
DBVT
$ 9.71 -2.8 % $ 1.36 B Nasdaq Global Select Market franceFrance
Allogene Therapeutics Allogene Therapeutics
ALLO
$ 0.7 -6.1 % $ 154 M Nasdaq Global Select Market,SPB usaUSA
Altimmune Altimmune
ALT
$ 1.38 -9.8 % $ 122 M Nasdaq Global Market usaUSA
AnaptysBio AnaptysBio
ANAB
$ 46.44 1.82 % $ 1.35 B Nasdaq Global Select Market,SPB usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
- -1.52 % $ 24.7 M Nasdaq Capital Market usaUSA
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
$ 270.27 -0.34 % $ 16.4 B Nasdaq Global Select Market danmarkDanmark
Precision BioSciences Precision BioSciences
DTIL
$ 7.1 0.64 % $ 91.1 M Nasdaq Global Select Market usaUSA
Arcturus Therapeutics Holdings Arcturus Therapeutics Holdings
ARCT
$ 8.03 0.75 % $ 220 M Nasdaq Global Market,SPB israelIsrael
Aurinia Pharmaceuticals Aurinia Pharmaceuticals
AUPH
$ 15.13 -1.79 % $ 2.03 B Nasdaq Global Market canadaCanada
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
$ 1.07 -2.29 % $ 285 M Nasdaq Global Select Market britainBritain
Atea Pharmaceuticals Atea Pharmaceuticals
AVIR
$ 3.99 0.71 % $ 325 M Nasdaq Global Select Market usaUSA
Exelixis Exelixis
EXEL
$ 68.26 -0.35 % $ 18.5 B Nasdaq Global Select Market,SPB usaUSA
Axsome Therapeutics Axsome Therapeutics
AXSM
$ 133.97 -1.46 % $ 6.66 B Nasdaq Global Market,SPB usaUSA
BridgeBio Pharma BridgeBio Pharma
BBIO
$ 77.98 1.54 % $ 14.9 B Nasdaq Global Select Market,SPB usaUSA
BioCryst Pharmaceuticals BioCryst Pharmaceuticals
BCRX
$ 7.31 -2.6 % $ 1.53 B Nasdaq Global Select Market usaUSA
Bicycle Therapeutics plc Bicycle Therapeutics plc
BCYC
$ 3.1 -3.13 % $ 215 M Nasdaq Global Select Market britainBritain
CollPlant Biotechnologies Ltd. CollPlant Biotechnologies Ltd.
CLGN
$ 4.64 17.17 % $ 56.6 M Nasdaq Capital Market israelIsrael
Biohaven Pharmaceutical Holding Company Ltd. Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$ 12.93 -2.34 % $ 836 M NYSE usaUSA
InMed Pharmaceuticals InMed Pharmaceuticals
INM
$ 15.56 13.57 % $ 64.8 M Nasdaq Capital Market canadaCanada
Immutep Limited Immutep Limited
IMMP
$ 3.29 0.92 % $ 4.79 B Nasdaq Global Market australiaAustralia
BeyondSpring BeyondSpring
BYSI
$ 0.46 -18.4 % $ 18.9 M Nasdaq Capital Market usaUSA
Cabaletta Bio Cabaletta Bio
CABA
$ 1.06 3.43 % $ 107 M Nasdaq Global Select Market usaUSA
C4 Therapeutics C4 Therapeutics
CCCC
$ 2.48 -2.17 % $ 206 M Nasdaq Global Select Market usaUSA
Coherus BioSciences Coherus BioSciences
CHRS
$ 0.41 -14.71 % $ 48 M Nasdaq Global Market usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
$ 27.63 -1.46 % $ 1.84 B Nasdaq Global Select Market usaUSA
Cellectis S.A. Cellectis S.A.
CLLS
$ 1.02 -3.42 % $ 102 M Nasdaq Global Market franceFrance
Armata Pharmaceuticals Armata Pharmaceuticals
ARMP
$ 3.13 17.67 % $ 113 M NYSE American usaUSA
Edesa Biotech Edesa Biotech
EDSA
$ 2.07 5.61 % $ 11.8 M Nasdaq Capital Market usaUSA
Collegium Pharmaceutical Collegium Pharmaceutical
COLL
$ 26.02 1.84 % $ 824 M Nasdaq Global Select Market usaUSA
GlaxoSmithKline plc GlaxoSmithKline plc
GSK
$ 48.61 -1.28 % $ 197 B NYSE britainBritain
CorMedix CorMedix
CRMD
$ 4.51 -3.53 % $ 325 K Nasdaq Global Market usaUSA
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
$ 40.19 0.09 % $ 3.61 B Nasdaq Global Market,SPB schweizSchweiz
Forte Biosciences Forte Biosciences
FBRX
$ 76.99 0.03 % $ 997 M Nasdaq Capital Market usaUSA
Champions Oncology Champions Oncology
CSBR
$ 4.59 0.04 % $ 63.5 M Nasdaq Capital Market usaUSA
Fennec Pharmaceuticals Fennec Pharmaceuticals
FENC
$ 13.29 -2.14 % $ 380 M Nasdaq Capital Market usaUSA
Cytokinetics, Incorporated Cytokinetics, Incorporated
CYTK
$ 51.27 -0.74 % $ 6.16 M Nasdaq Global Select Market,SPB usaUSA
Immunome Immunome
IMNM
$ 16.67 -2.97 % $ 1.46 B Nasdaq Global Select Market usaUSA
Immunic Immunic
IMUX
$ 7.53 2.73 % $ 1.17 B Nasdaq Global Select Market usaUSA
Immunovant Immunovant
IMVT
$ 33.18 -0.09 % $ 6.05 B Nasdaq Global Select Market usaUSA
Incyte Corporation Incyte Corporation
INCY
$ 117.79 -1.09 % $ 23 B Nasdaq Global Select Market,SPB usaUSA
Insmed Incorporated Insmed Incorporated
INSM
$ 120.17 -1.39 % $ 23.9 B Nasdaq Global Select Market usaUSA
Iovance Biotherapeutics Iovance Biotherapeutics
IOVA
$ 7.49 -0.6 % $ 2.68 M Nasdaq Global Market,SPB usaUSA
Dyadic International Dyadic International
DYAI
$ 0.32 1.27 % $ 11.6 M Nasdaq Capital Market usaUSA
Ironwood Pharmaceuticals Ironwood Pharmaceuticals
IRWD
$ 4.79 -1.75 % $ 775 M Nasdaq Global Select Market usaUSA
Fulcrum Therapeutics Fulcrum Therapeutics
FULC
$ 3.73 -0.67 % $ 284 M Nasdaq Global Market usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.